Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 1330 to 1379 of 8289 in total 
Value Type: Measured
Network Comparison Type: Divided
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Interaction Map\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
665\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
proto-oncogene tyrosine-protein kinase fgr (ec 2.7.1.112) (p55-fgr) (c-fgr). [source:swissprot;acc:p09769]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
8155.25\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8513.91\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04398\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
666\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
grb2-related adaptor protein 2 (gads protein) (growth factor receptor binding protein) (grblg) (grf40 adaptor protein) (grf-40) (grb-2-like protein) (grb2l) (grbx) (p38) (hematopoietic cell-associated adaptor protein grpl) (adapter protein grid) (sh3-sh2-sh3 adaptor mona). [source:swissprot;acc:o75791]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
8155.6\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8514.01\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04395\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
tbc1 domain family member 5. [source:swissprot;acc:q92609]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6374.65\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7145.59\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.12094\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
667\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i)/g(s)/g(t) beta subunit 3 (transducin beta chain 3). [source:swissprot;acc:p16520]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7930.27\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8278.46\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04391\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
tubby related protein 1 (tubby-like protein 1). [source:swissprot;acc:o00294]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6374.65\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7145.59\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.12094\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
668\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
nadp-dependent leukotriene b4 12-hydroxydehydrogenase (ec 1.1.1.-). [source:swissprot;acc:q14914]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8722.82\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9105.25\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04384\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar protein sorting 29 (vesicle protein sorting 29) (hvps29) (mds007) (pep11) (dc7/dc15). [source:swissprot;acc:q9ubq0]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6374.65\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
7145.59\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.12094\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
669\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
numb-like protein (numb-r). [source:swissprot;acc:q9y6r0]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
peroxisomal n1-acetyl-spermine/spermidine oxidase. [source:refseq;acc:nm\_152911]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
8843.04\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9230.12\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04377\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
670\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
neuron navigator 2 isoform l; retinoic acid inducible in neuroblastoma; pore membrane and/or filament interacting like protein 2; helicase helad1. [source:refseq;acc:nm\_145117]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
7887.93\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8232.61\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0437\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
tubby related protein 3 (tubby-like protein 3). [source:swissprot;acc:o75386]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6374.65\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7145.59\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.12094\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
671\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
potassium voltage-gated channel subfamily a member 2 (potassium channel kv1.2) (rbk2) (hbk5) (ngk1) (mk2) (hukiv). [source:swissprot;acc:p16389]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7812.88\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8154.08\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04367\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar protein sorting 35 (vesicle protein sorting 35) (hvps35) (maternal-embryonic 3). [source:swissprot;acc:q96qk1]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6374.65\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7145.59\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.12094\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
672\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
c18b11 homolog (44.9kd). [source:refseq;acc:nm\_152260]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7957.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8304.58\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04364\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
protein kinase c, zeta type (ec 2.7.1.37) (npkc-zeta). [source:swissprot;acc:q05513]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
6374.65\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7145.59\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.12094\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
673\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
transcription factor btf3 (rna polymerase b transcription factor 3). [source:swissprot;acc:p20290]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6933.17\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7766.54\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.1202\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
z-protein (protein cgi-119) (s1r protein). [source:swissprot;acc:q9hc24]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
7957.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8304.58\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.04364\vspace{3pt}}}\\\cline{1-2}\cline{4-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
674\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
homer, neuronal immediate early gene, 3. [source:refseq;acc:nm\_004838]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
7228.41\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7543.86\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
sprouty homolog 4 (spry-4). [source:swissprot;acc:q9c004]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5549.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6215.42\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.12006\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
675\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
neuron navigator 1; neuron navigator-1; pore membrane and/or filament interacting like protein 3. [source:refseq;acc:nm\_020443]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7886.87\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8230.98\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04363\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
sprouty homolog 3 (spry-3). [source:swissprot;acc:o43610]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5549.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6215.42\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.12006\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
676\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
neuron navigator 3; pore membrane and/or filament interacting like protein 1; steerin 3. [source:refseq;acc:nm\_014903]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7886.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8231.03\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04363\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
sprouty homolog 1 (spry-1) (fragment). [source:swissprot;acc:o43609]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5549.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6215.42\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.12006\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
677\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
potassium voltage-gated channel subfamily a member 1 (potassium channel kv1.1) (huki) (hbk1). [source:swissprot;acc:q09470]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7811.41\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8152.1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04361\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
sprouty homolog 2 (spry-2). [source:swissprot;acc:o43597]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5549.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6215.42\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.12006\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
678\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
homer, neuronal immediate early gene, 1b. [source:refseq;acc:nm\_004272]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7228.53\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7543.66\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0436\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
transcription factor btf3 homolog 3. [source:swissprot;acc:q13892]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
6938.22\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7770.65\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11998\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
679\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
adenylosuccinate synthase-like 1. [source:refseq;acc:nm\_152328]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6503.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7282.94\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11992\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
contactin 2 precursor (axonin-1) (axonal glycoprotein tag-1) (transient axonal glycoprotein 1) (tax-1). [source:swissprot;acc:q02246]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8154.34\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8509.76\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04359\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
680\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
adenylosuccinate synthetase (ec 6.3.4.4) (imp--aspartate ligase) (adss) (ampsase). [source:swissprot;acc:p30520]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6503.03\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7282.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11986\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
contactin 5 isoform long; neural adhesion molecule. [source:refseq;acc:nm\_014361]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
8154.34\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
8509.76\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.04359\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
681\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
contactin 6; neural adhesion molecule. [source:refseq;acc:nm\_014461]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ribosomal protein l24-like; 60s ribosomal protein l30 isolog; my024 protein; homolog of yeast ribosomal like protein 24. [source:refseq;acc:nm\_016304]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7170.83\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8029.64\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11976\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
682\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
putative homeodomain transcription factor 1. [source:swissprot;acc:q9ums5]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8154.34\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8509.76\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04359\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
syntaxin 12. [source:refseq;acc:nm\_177424]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5552.92\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6217.59\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.1197\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
683\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
mg81 protein (fragment). [source:sptrembl;acc:q14830]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8154.34\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8509.76\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04359\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
sh3-containing grb2-like protein 1 (sh3 domain protein 2b) (extra eleven-nineteen leukemia fusion gene) (een) (een fusion partner of mll). [source:swissprot;acc:q99961]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7139.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7994.06\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11969\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
684\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
contactin precursor (glycoprotein gp135). [source:swissprot;acc:q12860]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8154.34\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8509.76\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04359\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
eukaryotic translation initiation factor 3 subunit 9 (eif-3 eta) (eif3 p116) (eif3 p110) (eif3b). [source:swissprot;acc:p55884]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
4359.82\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4880.99\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11954\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
685\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
metaxin 1. [source:swissprot;acc:q13505]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
9327.58\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10442.2\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.1195\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
putative homeodomain transcription factor 2; hypothetical protein dkfzp564f013. [source:refseq;acc:nm\_020432]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8154.34\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8509.76\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04359\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
686\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
5'-amp-activated protein kinase, gamma-1 subunit (ampk gamma-1 chain) (ampkg). [source:swissprot;acc:p54619]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6920.69\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7747.63\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11949\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
elovl family member 6, elongation of long chain fatty acids (fen1/elo2, sur4/elo3-like, yeast); long-chain fatty-acyl elongase. [source:refseq;acc:nm\_024090]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8268.77\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8629.13\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04358\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
687\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
5'-amp-activated protein kinase, catalytic alpha-2 chain (ec 2.7.1.-) (ampk alpha-2 chain). [source:swissprot;acc:p54646]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6920.71\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7747.65\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11949\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
potassium voltage-gated channel subfamily a member 4 (potassium channel kv1.4) (hk1) (hpcn2) (hbk4) (hukii). [source:swissprot;acc:p22459]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7810.35\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8150.66\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04357\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
688\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
5'-amp-activated protein kinase, catalytic alpha-1 chain (ec 2.7.1.-) (ampk alpha-1 chain). [source:swissprot;acc:q13131]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6920.67\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7747.6\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11949\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
cytochrome b5 reductase b5r.2. [source:refseq;acc:nm\_016229]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8146.33\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8500.96\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04353\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
689\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
5'-amp-activated protein kinase, beta-2 subunit (ampk beta-2 chain). [source:swissprot;acc:o43741]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6920.69\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7747.63\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11949\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
paxillin. [source:swissprot;acc:p49023]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7804.55\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8143.54\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04343\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
690\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
5'-amp-activated protein kinase, gamma-3 subunit (ampk gamma-3 chain) (ampk gamma3). [source:swissprot;acc:q9ugi9]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6920.69\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7747.63\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11949\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/